SENZA.ST Current Ratio

The Current Ratio of SenzaGen AB (SENZA.ST) is 2.66.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

SENZA.ST Current Ratio - Historical Value

Date	Value
2024-12-31	2.66
2023-12-31	1.45
2022-12-31	1.98
2021-12-31	3.56
2020-12-31	25.05
2019-12-31	14.13
2018-12-31	10.97
2017-12-31	11.74
2016-12-31	10.56
2015-12-31	17.90

SENZA.ST Current Ratio - Peers Comparison

Ticker	Name	Value
PROMO.ST	Promore Pharma AB	3.33
ALLR.ST	Allarity Therapeutics A/S	0.40
ATORX.ST	Alligator Bioscience AB	0.35
LIDDS.ST	Lidds AB	4.86
KURN.SW	Kuros Biosciences AG	2.14
MTPH.L	Midatech Pharma PLC	6.39
PROB.ST	Probi AB	6.94
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	1.04
SPRINT.ST	Sprint Bioscience AB	1.14
ALNEV.PA	Neovacs SA	1.03
HNSA.ST	Hansa Biopharma AB	2.29
ISR.ST	ISR Immune System Regulation Holding AB (publ)	0.03
XINT.ST	Xintela AB	0.78
RDG.WA	Read Gene SA	10.30
ACTI.ST	Active Biotech AB publ	4.40
GEN.WA	Genomed SA	6.28
PUR.WA	Pure Biologics SA	2.60
SCS.WA	Stem Cells Spin SA	0.16
XBRANE.ST	Xbrane Biopharma AB	1.13
AEGIR.ST	Aegirbio AB	1.64
ALPAT.PA	Plant Advanced Technologies PAT SA	2.11
IMMU.ST	Mendus AB (publ)	4.29
VAL.L	ValiRx PLC	2.64
BIOA B.ST	BioArctic AB	5.75
IVACC.ST	Intervacc AB	2.03
MVIR B.ST	Medivir AB	4.39
GUARD.ST	Guard Therapeutics International AB (publ)	3.14
GV.PA	Genomic Vision SA	0.91
ABNX.PA	Abionyx Pharma SA	1.58
ALNOX.PA	Noxxon Pharma NV	1.84
BIOG B.ST	Biogaia AB	7.81
ALPRE.PA	Predilife SA	3.22
VITR.ST	Vitrolife AB	3.34
T5O.DE	bioXXmed AG	44.34
ALGEN.PA	Genoway SA	2.06
BONEX.ST	Bonesupport Holding AB	4.32
EVG.L	Evgen Pharma PLC	7.36